This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Innovation & Partnership Summit
March 21-23, 2023
Delivered as a Hybrid EventPhiladelphia Marriott Downtown

Chowdary Dondapati
Head, CDx Marketing, Precision Medicine (US) at Bayer Oncology


Chowdary Dondapati is a trained cancer biologist with an extensive experience in precision oncology, from setting a global strategy to implementing local tactics. He has held several leadership roles in advancing precision medicine - running a CLIA reference laboratory, leading oncology biomarker development, market development, commercial launch of FDA cleared diagnostic systems & kits, innovative patient identification strategies for therapy. He did his doctoral thesis at Hunter College in city of New York, NY and MBA at Rutgers Business school in city of Newark, NJ

Agenda Sessions

  • The 4 Ps of Advancing Precision Medicine – Patients, Providers, Partners and Pharma